Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne mu...
President Biden ordered the nation’s leading health agencies on Monday to develo...
Cassava Sciences has long claimed its drug slows the cognitive decline of people...
Want to stay on top of the science and politics driving biotech today? Sign up t...
The FDA disclosed safety concerns about a CRISPR-based treatment for sickle cell...
A large increase in greenhouse gas emissions would lead to a 233% increase in ex...
Direct-to-consumer telehealth options are proliferating for low-complexity visit...
In the next few weeks, Sarepta Therapeutics will release new data that could cha...
A marijuana black market became a multibillion-dollar driver of Colorado's econo...
Just as hospitals’ contract labor problem eases, another is taking its place: ph...
Outgoing Bristol CEO Giovanni Caforio sat for an exit interview with @matthewher...
Liquid biopsy for cancer recurrence creates a new kind of patient-in-waiting.
The Senate Finance Committee plans to move ahead with a wide-ranging health care...
The Biden administration is slowly shifting millions of Covid-19 treatments to p...
While there are a number of studies demonstrating that dog therapy programs can ...
BINGHAMTON, N.Y. — The federal government designated the New Energy New York (NE...
